Bulk Manufacturer of Controlled Substances Application: Alcami Wisconsin Corporation

Published date08 August 2019
Citation84 FR 39016
Record Number2019-17002
SectionNotices
CourtDrug Enforcement Administration,Justice Department
Federal Register, Volume 84 Issue 153 (Thursday, August 8, 2019)
[Federal Register Volume 84, Number 153 (Thursday, August 8, 2019)]
                [Notices]
                [Page 39016]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2019-17002]
                -----------------------------------------------------------------------
                DEPARTMENT OF JUSTICE
                Drug Enforcement Administration
                [Docket No. DEA-392]
                Bulk Manufacturer of Controlled Substances Application: Alcami
                Wisconsin Corporation
                ACTION: Notice of application.
                -----------------------------------------------------------------------
                DATES: Registered bulk manufacturers of the affected basic classes, and
                applicants therefore, may file written comments on or objections to the
                issuance of the proposed registration on or before October 7, 2019.
                ADDRESSES: Written comments should be sent to: Drug Enforcement
                Administration, Attention: DEA Federal Register Representative/DPW,
                8701 Morrissette Drive, Springfield, Virginia 22152.
                SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
                is notice that on March 12 2019, Alcami Wisconsin Corporation,
                W130N10497 Washington Drive, Germantown, Wisconsin 53022 applied to be
                registered as a bulk manufacturer of the following basic classes of
                controlled substances:
                ------------------------------------------------------------------------
                 Drug
                 Controlled substance code Schedule
                ------------------------------------------------------------------------
                Marihuana Extract....................... 7350 I
                Marihuana............................... 7360 I
                Tetrahydrocannabinols................... 7370 I
                5-Methoxy-N-N-dimethyltryptamine........ 7431 I
                Thebaine................................ 9333 II
                Alfentanil.............................. 9737 II
                ------------------------------------------------------------------------
                 The company plans to provide bulk active pharmaceutical ingredient
                to support clinical trials. In reference to drug codes 7350 marihuana
                extract, 7360 marihuana, and 7360 THC, the company plans to
                manufacturer these substances synthetically. No other activity for
                these drug codes is authorized for this registration.
                 Dated: July 30, 2019.
                John J. Martin,
                Assistant Administrator.
                [FR Doc. 2019-17002 Filed 8-7-19; 8:45 am]
                BILLING CODE 4410-09-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT